Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial Comparing Cyanoacrylate Injection Versus Beta-Blockers Versus No Treatment for Primary Prophylaxis of Gastric Variceal Bleed
In patients who have never bled from gastric varix (GOV2 and IGV1), cyanoacrylate injection will be better than both beta-blocker therapy and no treatment in prevention of gastric variceal bleed. The investigators conducted a randomized controlled trial in patients with gastric varix (GOV2 and IGV1) who never bled before, to study the efficacy of treatment with cyanoacrylate injection versus beta-blocker versus no treatment in prevention of first bleed from gastric varices.
Patients are followed up every 3 months or at the time of end point or complications.
Age
12 - 75 years
Sex
ALL
Healthy Volunteers
No
Shiv K Sarin
New Delhi, National Capital Territory of Delhi, India
Start Date
August 1, 2006
Primary Completion Date
January 1, 2009
Completion Date
January 1, 2009
Last Updated
May 21, 2009
74
ACTUAL participants
Endoscopic cyanoacrylate injection
PROCEDURE
Beta-blocker (propranolol)
DRUG
Lead Sponsor
Govind Ballabh Pant Hospital
NCT05597488
NCT06932783
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06306963